Form D · Biotechnology
Kineticos Disruptor Fund NU7, LLC
Raleigh, NC · CIK 0001842955
Offering snapshot reported Feb 3, 2021 · SEC filing
- Reported sold
- $212K Offering amount: $212K
- Investors reported
- 5 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jan 25, 2021 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Feb 3, 2021 | Initial | $212,000 | No comparison | 5 | SEC filing |
Offering details
- Securities
- Pooled investment fund
- Exemptions
- 06b, 3C, 3C.1
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-388257
Source: Form D, filed Feb 3, 2021. Minimum accepted may differ from a standard advertised minimum.
Fund connections
The linked fund shows its most recently reported ADV details.
Matched by reported Form D file number
KINETICOS DISRUPTOR FUND NU7, LLC
Investment adviser: KINETICOS LIFE SCIENCES MANAGEMENT LLC
- Gross asset value
- $779K
- Beneficial owners
- 5
- ADV minimum commitment
- $0
Reported in Form ADV on Mar 26, 2026. Fund assets and beneficial owners measure different things from Form D sales and investors.
Service providers
Provider details
- Annual audit
- No
- Prime brokers
- No
- Custodians
- Yes
- Administrator other than the adviser
- Yes
- External marketing
- No
Filing source
Form ADV 2079386 · Mar 26, 2026 · Schedule D 7.B.(1), fund 805-3048223004
Official IAPD profile (latest public filing). Values are the most recently reported in our imported data; the public profile may show a newer filing.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Abraham Surinder Maingi | Director, Executive |
| Shailesh Maingi | Promoter |
Issuer details
Industry: Biotechnology (See others in industry)
Address:Raleigh, NC, 27615